A61L 2300/402
Anaestetics, analgesics
Official title: Anaestetics, analgesics, e.g. lidocaine
A61L2300/402 (Anaestetics, analgesics) appears on 468 US grants and 773 published applications in this corpus.
Search patents in A61L- Granted patents
- 468
- Published applications
- 773
- Assignees
- 357
- Inventors
- 1,254
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 5 | 0 |
| 1998 | 9 | 0 |
| 1999 | 9 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 5 |
| 2002 | 11 | 8 |
| 2003 | 6 | 19 |
| 2004 | 3 | 10 |
| 2005 | 5 | 14 |
| 2006 | 5 | 20 |
| 2007 | 6 | 38 |
| 2008 | 2 | 31 |
| 2009 | 4 | 20 |
| 2010 | 10 | 33 |
| 2011 | 13 | 32 |
| 2012 | 17 | 36 |
| 2013 | 31 | 37 |
| 2014 | 33 | 42 |
| 2015 | 35 | 42 |
| 2016 | 34 | 47 |
| 2017 | 28 | 28 |
| 2018 | 22 | 39 |
| 2019 | 26 | 37 |
| 2020 | 21 | 38 |
| 2021 | 21 | 46 |
| 2022 | 13 | 27 |
| 2023 | 14 | 43 |
| 2024 | 20 | 34 |
| 2025 | 24 | 26 |
| 2026 | 10 | 21 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ready-to-use esthetic compositions7 Jul 2026US 12,673,131 B2Galderma Holding SA
- Embolization hydrogel having controllable degradation time, and preparation method therefor9 Jun 2026US 12,649,015 B2Nextbiomedical Co., Ltd.
- Silk-hyaluronic acid based tissue filers and methods of using the same28 Apr 2026US 12,611,484 B2Evolved By Nature, Inc.
- Tough gel-based drug delivery compositions and methods thereof21 Apr 2026US 12,605,480 B2President and Fellows of Harvard College
- Nanoparticles to promote wound healing and antimicrobial infection control21 Apr 2026US 12,605,485 B2Kismet Technologies Inc.
- Trodusquemine-coated balloon for targeted treatment of atherosclerosis8 Oct 2026US 2026/0306719 A1Bard Peripheral Vascular, Inc.
- Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof1 Oct 2026US 2026/0295116 A1MERZ PHARMA GmbH & CO. KGaA
- Hyaluronic acid-based gels including lidocaine24 Sep 2026US 2026/0284270 A1Allergan Industrie, SAS
- Sustained Release Liposomal Pharmaceutical Embolizing Agents for Treating Chronic Subdural Hematoma, Intractable Migraines, Headaches, and Other Pain Conditions17 Sep 2026US 2026/0272468 A1MG Stroke Analytics Inc.
- Systems and methods for treating scars9 Jul 2026US 2026/0191557 A1
Most cited
By later US patents
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Anti-infective and anti-inflammatory releasing systems for medical devices379US 5,512,055 A1996
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000
- Drug releasing surgical implant or dressing material275US 5,972,366 AThe Unites States of America as represented by the Secretary of the Army · 1999
- Binder coated discontinuous fibers with adhered particulate materials234US 5,432,000 AWeyerhaeuser Company · 1995